198 results
S-8
EX-99.3
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
. The Exercise Price may be paid in Common Stock, cash or a combination thereof, including an irrevocable commitment by a broker to pay over such amount from … to the Company by cash or check in connection with the exercise of the Option (including an irrevocable commitment by a broker to pay over
S-8
EX-99.2
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
commitment by a broker to pay over such amount from a sale of the Common Stock issuable under the Option, the delivery of previously owned Common Stock … an irrevocable commitment by a broker to pay over such amount from a sale of the Common Stock issuable under the Option), withholding may be effected
8-K
EX-99.1
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Report of Independent Registered Public Accounting Firm
4:56pm
(i) the closing of a firm-commitment underwritten public offering of the Company’s common stock at a price of at least $12.00 per share resulting
8-K
EX-10.1
pg2 ork5f
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
8-K
EX-14.1
1vw1id k4e
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.3
36fne9b4 3x0
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
2a92 du509xu1o9
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.2
r37iy
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-3.6
bjixgel p8qau
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
sy43a
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
425
EX-10.1
pnhasba9ql9um0t4
15 Aug 24
Business combination disclosure
4:17pm
8-K
EX-10.1
fyur2an5563
15 Aug 24
Entry into a Material Definitive Agreement
4:15pm
424B3
wxea02
1 Aug 24
Prospectus supplement
4:10pm
425
EX-10.2
naletimr
9 Jul 24
Business combination disclosure
5:04pm
8-K
EX-10.2
q9ryz1
9 Jul 24
Entry into a Material Definitive Agreement
5:01pm